{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T09:49:36Z","timestamp":1776937776350,"version":"3.51.4"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-06793-x","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T02:22:02Z","timestamp":1771640522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Surfactant therapy in neonatal care: advances, challenges, and practical considerations"],"prefix":"10.1007","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1226-3345","authenticated-orcid":false,"given":"Asghar","family":"Marzban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8635-2253","authenticated-orcid":false,"given":"Pouya","family":"Karami Dehkordi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"issue":"6","key":"6793_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2024.101374","volume":"6","author":"DS Berger","year":"2024","unstructured":"Berger DS et al (2024) Respiratory distress syndrome is associated with increased morbidity and mortality in late preterm births. Am J Obstet Gynecol MFM 6(6):101374","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"2","key":"6793_CR2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41390-020-0750-8","volume":"88","author":"R Hentschel","year":"2020","unstructured":"Hentschel R et al (2020) Surfactant replacement therapy: from biological basis to current clinical practice. Pediatr Res 88(2):176\u2013183","journal-title":"Pediatr Res"},{"key":"6793_CR3","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1146\/annurev.physiol.62.1.825","volume":"62","author":"AH Jobe","year":"2000","unstructured":"Jobe AH, Ikegami M (2000) Lung development and function in preterm infants in the surfactant treatment era. Annu Rev Physiol 62:825\u2013846","journal-title":"Annu Rev Physiol"},{"key":"6793_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/children10030535","author":"M Tana","year":"2023","unstructured":"Tana M et al (2023) Respiratory management of the preterm infant: supporting evidence-based practice at the bedside. Children. https:\/\/doi.org\/10.3390\/children10030535","journal-title":"Children"},{"key":"6793_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2174\/1874306401206010044","volume":"6","author":"CC Ma","year":"2012","unstructured":"Ma CC, Ma S (2012) The role of surfactant in respiratory distress syndrome. Open Respir Med J 6:44\u201353","journal-title":"Open Respir Med J"},{"key":"6793_CR6","unstructured":"Yadav S and B Lee (2025) Neonatal Respiratory Distress Syndrome, in StatPearls. Treasure Island (FL)"},{"issue":"11","key":"6793_CR7","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1080\/14767058.2019.1646240","volume":"34","author":"C Siffel","year":"2021","unstructured":"Siffel C et al (2021) Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review. J Matern Fetal Neonatal Med 34(11):1721\u20131731","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"6793_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1542\/peds.2013-3443","volume":"133","author":"RA Polin","year":"2014","unstructured":"Polin RA et al (2014) Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics 133(1):156\u2013163","journal-title":"Pediatrics"},{"issue":"4","key":"6793_CR9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1159\/000499361","volume":"115","author":"DG Sweet","year":"2019","unstructured":"Sweet DG et al (2019) European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update. Neonatology 115(4):432\u2013450","journal-title":"Neonatology"},{"issue":"5","key":"6793_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.7848","volume":"4","author":"R Ramanathan","year":"2021","unstructured":"Ramanathan R (2021) Surfactant treatment-a national, population-based study of adherence to best practice, off-label use, and associations with outcomes. JAMA Netw Open 4(5):e217848","journal-title":"JAMA Netw Open"},{"issue":"1","key":"6793_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000528914","volume":"120","author":"DG Sweet","year":"2023","unstructured":"Sweet DG et al (2023) European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update. Neonatology 120(1):3\u201323","journal-title":"Neonatology"},{"issue":"6","key":"6793_CR12","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.bbamem.2014.01.028","volume":"1838","author":"E Lopez-Rodriguez","year":"2014","unstructured":"Lopez-Rodriguez E, Perez-Gil J (2014) Structure-function relationships in pulmonary surfactant membranes: from biophysics to therapy. Biochim Biophys Acta 1838(6):1568\u20131585","journal-title":"Biochim Biophys Acta"},{"key":"6793_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00018","volume":"5","author":"GL Sorensen","year":"2018","unstructured":"Sorensen GL (2018) Surfactant protein D in respiratory and non-respiratory diseases. Front Med 5:18","journal-title":"Front Med"},{"issue":"23","key":"6793_CR14","doi-asserted-by":"publisher","first-page":"13209","DOI":"10.1021\/acs.chemrev.3c00146","volume":"123","author":"F Possmayer","year":"2023","unstructured":"Possmayer F et al (2023) Pulmonary surfactant: a mighty thin film. Chem Rev 123(23):13209\u201313290","journal-title":"Chem Rev"},{"issue":"7","key":"6793_CR15","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1073\/pnas.75.7.3417","volume":"75","author":"S Schurch","year":"1978","unstructured":"Schurch S, Goerke J, Clements JA (1978) Direct determination of volume- and time-dependence of alveolar surface tension in excised lungs. Proc Natl Acad Sci USA 75(7):3417\u20133421","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"6793_CR16","first-page":"132","volume":"25","author":"J Perez-Gil","year":"2010","unstructured":"Perez-Gil J, Weaver TE (2010) Pulmonary surfactant pathophysiology: current models and open questions. Physiology (Bethesda) 25(3):132\u2013141","journal-title":"Physiology (Bethesda)"},{"issue":"12","key":"6793_CR17","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.bpj.2024.04.021","volume":"123","author":"SB Hall","year":"2024","unstructured":"Hall SB, Zuo YY (2024) The biophysical function of pulmonary surfactant. Biophys J 123(12):1519\u20131530","journal-title":"Biophys J"},{"issue":"6","key":"6793_CR18","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1016\/S0006-3495(00)76550-7","volume":"79","author":"EJ Veldhuizen","year":"2000","unstructured":"Veldhuizen EJ et al (2000) The role of surfactant proteins in DPPC enrichment of surface films. Biophys J 79(6):3164\u20133171","journal-title":"Biophys J"},{"key":"6793_CR19","doi-asserted-by":"crossref","unstructured":"Canadas O et al (2020) Lipid-Protein and Protein-Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis. Int J Mol Sci 21(10)","DOI":"10.3390\/ijms21103708"},{"key":"6793_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.581016","volume":"8","author":"J Liekkinen","year":"2020","unstructured":"Liekkinen J et al (2020) Understanding the functional properties of lipid heterogeneity in pulmonary surfactant monolayers at the atomistic level. Front Cell Dev Biol 8:581016","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"6793_CR21","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1513\/AnnalsATS.201411-507FR","volume":"12","author":"S Han","year":"2015","unstructured":"Han S, Mallampalli RK (2015) The role of surfactant in lung disease and host defense against pulmonary infections. Ann Am Thorac Soc 12(5):765\u2013774","journal-title":"Ann Am Thorac Soc"},{"key":"6793_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jconrel.2018.10.012","volume":"291","author":"R Guagliardo","year":"2018","unstructured":"Guagliardo R et al (2018) Pulmonary surfactant and drug delivery: focusing on the role of surfactant proteins. J Control Release 291:116\u2013126","journal-title":"J Control Release"},{"issue":"2","key":"6793_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2174\/157489110791233559","volume":"5","author":"S Awasthi","year":"2010","unstructured":"Awasthi S (2010) Surfactant protein (SP)-A and SP-D as antimicrobial and immunotherapeutic agents. Recent Pat Antiinfect Drug Discov 5(2):115\u2013123","journal-title":"Recent Pat Antiinfect Drug Discov"},{"issue":"2","key":"6793_CR24","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1529\/biophysj.106.090217","volume":"92","author":"A Saenz","year":"2007","unstructured":"Saenz A et al (2007) Effect of surfactant protein A on the physical properties and surface activity of KL4-surfactant. Biophys J 92(2):482\u2013492","journal-title":"Biophys J"},{"issue":"3","key":"6793_CR25","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.bbalip.2012.09.010","volume":"1831","author":"M Agassandian","year":"2013","unstructured":"Agassandian M, Mallampalli RK (2013) Surfactant phospholipid metabolism. Biochim Biophys Acta 1831(3):612\u2013625","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"6793_CR26","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1172\/JCI200318650","volume":"111","author":"JR Wright","year":"2003","unstructured":"Wright JR (2003) Pulmonary surfactant: a front line of lung host defense. J Clin Invest 111(10):1453\u20131455","journal-title":"J Clin Invest"},{"issue":"1","key":"6793_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000492974","volume":"11","author":"A Watson","year":"2019","unstructured":"Watson A et al (2019) Surfactant proteins A and D: trimerized innate immunity proteins with an affinity for viral fusion proteins. J Innate Immun 11(1):13\u201328","journal-title":"J Innate Immun"},{"issue":"11","key":"6793_CR28","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1136\/adc.88.11.981","volume":"88","author":"H Clark","year":"2003","unstructured":"Clark H, Reid K (2003) The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema. Arch Dis Child 88(11):981\u2013984","journal-title":"Arch Dis Child"},{"issue":"8","key":"6793_CR29","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1016\/j.bbamcr.2016.04.028","volume":"1863","author":"N Hobi","year":"2016","unstructured":"Hobi N et al (2016) A small key unlocks a heavy door: the essential function of the small hydrophobic proteins SP-B and SP-C to trigger adsorption of pulmonary surfactant lamellar bodies. Biochim Biophys Acta 1863(8):2124\u20132134","journal-title":"Biochim Biophys Acta"},{"key":"6793_CR30","doi-asserted-by":"publisher","DOI":"10.1159\/000451076","author":"FJ Walther","year":"2016","unstructured":"Walther FJ, Gordon LM, Waring AJ (2016) Design of surfactant protein B peptide mimics based on the saposin fold for synthetic lung surfactants. Biomed Hub. https:\/\/doi.org\/10.1159\/000451076","journal-title":"Biomed Hub"},{"issue":"6","key":"6793_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2023.101503","volume":"28","author":"F Moya","year":"2023","unstructured":"Moya F et al (2023) Synthetic surfactants. Semin Fetal Neonatal Med 28(6):101503","journal-title":"Semin Fetal Neonatal Med"},{"issue":"2","key":"6793_CR32","doi-asserted-by":"publisher","first-page":"L257","DOI":"10.1152\/ajplung.00054.2011","volume":"302","author":"RD Hite","year":"2012","unstructured":"Hite RD et al (2012) Surfactant protein B inhibits secretory phospholipase A2 hydrolysis of surfactant phospholipids. Am J Physiol Lung Cell Mol Physiol 302(2):L257\u2013L265","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"6793_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13182964","author":"A Dushianthan","year":"2023","unstructured":"Dushianthan A et al (2023) Pulmonary surfactant in adult ARDS: current perspectives and future directions. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics13182964","journal-title":"Diagnostics (Basel)"},{"issue":"10","key":"6793_CR34","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1016\/j.bpj.2009.08.045","volume":"97","author":"L Gomez-Gil","year":"2009","unstructured":"Gomez-Gil L et al (2009) Pulmonary surfactant protein SP-C counteracts the deleterious effects of cholesterol on the activity of surfactant films under physiologically relevant compression-expansion dynamics. Biophys J 97(10):2736\u20132745","journal-title":"Biophys J"},{"issue":"12","key":"6793_CR35","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1021\/acs.langmuir.2c03349","volume":"39","author":"J Liekkinen","year":"2023","unstructured":"Liekkinen J et al (2023) Surfactant proteins SP-B and SP-C in pulmonary surfactant monolayers: physical properties controlled by specific protein-lipid interactions. Langmuir 39(12):4338\u20134350","journal-title":"Langmuir"},{"issue":"1","key":"6793_CR36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nri1528","volume":"5","author":"JR Wright","year":"2005","unstructured":"Wright JR (2005) Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 5(1):58\u201368","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"6793_CR37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2741\/3935","volume":"17","author":"P Silveyra","year":"2012","unstructured":"Silveyra P, Floros J (2012) Genetic variant associations of human SP-A and SP-D with acute and chronic lung injury. Front Biosci (Landmark Ed) 17(2):407\u2013429","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"5","key":"6793_CR38","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1586\/eri.12.34","volume":"10","author":"I Bersani","year":"2012","unstructured":"Bersani I, Speer CP, Kunzmann S (2012) Surfactant proteins A and D in pulmonary diseases of preterm infants. Expert Rev Anti Infect Ther 10(5):573\u2013584","journal-title":"Expert Rev Anti Infect Ther"},{"key":"6793_CR39","doi-asserted-by":"publisher","first-page":"1639573","DOI":"10.3389\/fped.2025.1639573","volume":"13","author":"A Alonso-Ojembarrena","year":"2025","unstructured":"Alonso-Ojembarrena A et al (2025) A phase 1b randomized, multicenter, dose determination trial of zelpultide alfa (recombinant human surfactant protein D) in preterm neonates at high risk of developing bronchopulmonary dysplasia. Front Pediatr 13:1639573","journal-title":"Front Pediatr"},{"issue":"4","key":"6793_CR40","doi-asserted-by":"publisher","first-page":"L411","DOI":"10.1152\/ajplung.00079.2023","volume":"325","author":"D De Luca","year":"2023","unstructured":"De Luca D et al (2023) Early life surfactant protein-D levels in bronchoalveolar lavage fluids of extremely preterm neonates. Am J Physiol Lung Cell Mol Physiol 325(4):L411\u2013L418","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"6793_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2023.101501","volume":"28","author":"PA Dargaville","year":"2023","unstructured":"Dargaville PA, Herting E, Soll RF (2023) Neonatal surfactant therapy beyond respiratory distress syndrome. Semin Fetal Neonatal Med 28(6):101501","journal-title":"Semin Fetal Neonatal Med"},{"issue":"8","key":"6793_CR42","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S2213-2600(17)30214-X","volume":"5","author":"D De Luca","year":"2017","unstructured":"De Luca D et al (2017) The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity. Lancet Respir Med 5(8):657\u2013666","journal-title":"Lancet Respir Med"},{"issue":"1","key":"6793_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13054-021-03489-6","volume":"25","author":"D De Luca","year":"2021","unstructured":"De Luca D et al (2021) Surfactant therapies for pediatric and neonatal ARDS: ESPNIC expert consensus opinion for future research steps. Crit Care 25(1):75","journal-title":"Crit Care"},{"issue":"1","key":"6793_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/pch\/pxaa116","volume":"26","author":"EH Ng","year":"2021","unstructured":"Ng EH, Shah V (2021) Guidelines for surfactant replacement therapy in neonates. Paediatr Child Health 26(1):35\u201349","journal-title":"Paediatr Child Health"},{"issue":"2","key":"6793_CR45","doi-asserted-by":"publisher","first-page":"367","DOI":"10.4187\/respcare.02189","volume":"58","author":"BK Walsh","year":"2013","unstructured":"Walsh BK et al (2013) AARC clinical practice guideline. Surfactant replacement therapy: 2013. Respir Care 58(2):367\u2013375","journal-title":"Respir Care"},{"issue":"1","key":"6793_CR46","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41390-019-0344-5","volume":"86","author":"S Banerjee","year":"2019","unstructured":"Banerjee S et al (2019) Surfactant replacement therapy for respiratory distress syndrome in preterm infants: United Kingdom national consensus. Pediatr Res 86(1):12\u201314","journal-title":"Pediatr Res"},{"issue":"Suppl 1","key":"6793_CR47","first-page":"S45","volume":"53","author":"H Ozkan","year":"2018","unstructured":"Ozkan H, Erdeve O, Kutman HGK (2018) Turkish Neonatal Society guideline on the management of respiratory distress syndrome and surfactant treatment. Turk Pediatri Ars 53(Suppl 1):S45\u2013S54","journal-title":"Turk Pediatri Ars"},{"issue":"4","key":"6793_CR48","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.bj.2022.03.001","volume":"45","author":"J Perez-Gil","year":"2022","unstructured":"Perez-Gil J (2022) A recipe for a good clinical pulmonary surfactant. Biomed J 45(4):615\u2013628","journal-title":"Biomed J"},{"issue":"3","key":"6793_CR49","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1432-1033.1997.00675.x","volume":"244","author":"J Johansson","year":"1997","unstructured":"Johansson J, Curstedt T (1997) Molecular structures and interactions of pulmonary surfactant components. Eur J Biochem 244(3):675\u2013693","journal-title":"Eur J Biochem"},{"issue":"5","key":"6793_CR50","doi-asserted-by":"publisher","first-page":"e950","DOI":"10.1542\/peds.2009-0126","volume":"124","author":"PE Cogo","year":"2009","unstructured":"Cogo PE et al (2009) Dosing of porcine surfactant: effect on kinetics and gas exchange in respiratory distress syndrome. Pediatrics 124(5):e950\u2013e957","journal-title":"Pediatrics"},{"issue":"3","key":"6793_CR51","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00134-010-2091-2","volume":"37","author":"PE Cogo","year":"2011","unstructured":"Cogo PE et al (2011) Pharmacokinetics and clinical predictors of surfactant redosing in respiratory distress syndrome. Intensive Care Med 37(3):510\u2013517","journal-title":"Intensive Care Med"},{"issue":"1","key":"6793_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-0979-0","volume":"20","author":"A Tridente","year":"2019","unstructured":"Tridente A, De Martino L, De Luca D (2019) Porcine vs bovine surfactant therapy for preterm neonates with RDS: systematic review with biological plausibility and pragmatic meta-analysis of respiratory outcomes. Respir Res 20(1):28","journal-title":"Respir Res"},{"issue":"6","key":"6793_CR53","doi-asserted-by":"publisher","first-page":"553","DOI":"10.5152\/TurkArchPediatr.2021.21240","volume":"56","author":"O Erdeve","year":"2021","unstructured":"Erdeve O et al (2021) Alternative methods of surfactant administration in preterm infants with respiratory distress syndrome: state of the art. Turk Arch Pediatr 56(6):553\u2013562","journal-title":"Turk Arch Pediatr"},{"issue":"16","key":"6793_CR54","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJM199410203311603","volume":"331","author":"H Verder","year":"1994","unstructured":"Verder H et al (1994) Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med 331(16):1051\u20131055","journal-title":"N Engl J Med"},{"issue":"1","key":"6793_CR55","first-page":"CD008309","volume":"1","author":"ME Abdel-Latif","year":"2024","unstructured":"Abdel-Latif ME, Walker E, Osborn DA (2024) Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev 1(1):CD008309","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"6793_CR56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/archdischild-2021-321645","volume":"107","author":"L Jardine","year":"2022","unstructured":"Jardine L et al (2022) Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 107(1):51\u201355","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"6","key":"6793_CR57","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1007\/s00134-025-07932-y","volume":"51","author":"S Mongodi","year":"2025","unstructured":"Mongodi S et al (2025) ESICM-ESPNIC international expert consensus on quantitative lung ultrasound in intensive care. Intensive Care Med 51(6):1022\u20131049","journal-title":"Intensive Care Med"},{"issue":"5","key":"6793_CR58","doi-asserted-by":"publisher","first-page":"e2413446","DOI":"10.1001\/jamanetworkopen.2024.13446","volume":"7","author":"D De Luca","year":"2024","unstructured":"De Luca D et al (2024) Quantitative Lung Ultrasonography to Guide Surfactant Therapy in Neonates Born Late Preterm and Later. JAMA Netw Open 7(5):e2413446","journal-title":"JAMA Netw Open"},{"key":"6793_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105865","volume":"118","author":"D De Luca","year":"2025","unstructured":"De Luca D et al (2025) Quantitative lung ultrasound to guide surfactant retreatment in preterm neonates born at <\/=30 weeks\u2019 gestation: a multicentre retrospective non-inferiority diagnostic accuracy study. EBioMedicine 118:105865","journal-title":"EBioMedicine"},{"key":"6793_CR60","doi-asserted-by":"crossref","unstructured":"Sartorius V, S Brunet, and D De Luca (2025) Characteristics of scores used for quantitative lung ultrasound in neonates: a systematic review. Eur Respir Rev 34(176)","DOI":"10.1183\/16000617.0232-2024"},{"issue":"5","key":"6793_CR61","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/ppul.26337","volume":"58","author":"L Capasso","year":"2023","unstructured":"Capasso L et al (2023) Can lung ultrasound score accurately predict surfactant replacement? A systematic review and meta-analysis of diagnostic test studies. Pediatr Pulmonol 58(5):1427\u20131437","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"6793_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0287758","volume":"18","author":"K Luo","year":"2023","unstructured":"Luo K et al (2023) Optimal timing and cutoff range of lung ultrasound in predicting surfactant administration in neonates: a meta-analysis and systematic review. PLoS ONE 18(7):e0287758","journal-title":"PLoS ONE"},{"key":"6793_CR63","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0112-2024","author":"C Neri","year":"2025","unstructured":"Neri C, Sartorius V, De Luca D (2025) Transient tachypnoea: new concepts on the commonest neonatal respiratory disorder. Eur Respir Rev. https:\/\/doi.org\/10.1183\/16000617.0112-2024","journal-title":"Eur Respir Rev"},{"issue":"6","key":"6793_CR64","doi-asserted-by":"publisher","first-page":"101494","DOI":"10.1016\/j.siny.2023.101494","volume":"28","author":"D De Luca","year":"2023","unstructured":"De Luca D et al (2023) Surfactant status assessment and personalized therapy for surfactant deficiency or dysfunction. Semin Fetal Neonatal Med 28(6):101494","journal-title":"Semin Fetal Neonatal Med"},{"key":"6793_CR65","doi-asserted-by":"publisher","first-page":"44\u201352 e2","DOI":"10.1016\/j.jpeds.2022.11.037","volume":"256","author":"L Pezza","year":"2023","unstructured":"Pezza L et al (2023) Evolution of Ultrasound-Assessed Lung Aeration and Gas Exchange in Respiratory Distress Syndrome and Transient Tachypnea of the Neonate. J Pediatr 256:44-52 e2","journal-title":"J Pediatr"},{"key":"6793_CR66","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jpeds.2016.11.057","volume":"182","author":"C Autilio","year":"2017","unstructured":"Autilio C et al (2017) A noninvasive surfactant adsorption test predicting the need for surfactant therapy in preterm infants treated with continuous positive airway pressure. J Pediatr 182:66-73 e1","journal-title":"J Pediatr"},{"key":"6793_CR67","doi-asserted-by":"publisher","first-page":"1171223","DOI":"10.3389\/fped.2023.1171223","volume":"11","author":"AM Gezmu","year":"2023","unstructured":"Gezmu AM et al (2023) Pulmonary hemorrhage and associated risk factors among newborns admitted to a tertiary level neonatal unit in Botswana. Front Pediatr 11:1171223","journal-title":"Front Pediatr"},{"issue":"2","key":"6793_CR68","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3233\/NPM-1867","volume":"12","author":"M Lee","year":"2019","unstructured":"Lee M et al (2019) Pulmonary hemorrhage in neonatal respiratory distress syndrome: radiographic evolution, course, complications and long-term clinical outcomes. J Neonatal Perinatal Med 12(2):161\u2013171","journal-title":"J Neonatal Perinatal Med"},{"issue":"5","key":"6793_CR69","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3345\/kjp.2018.07185","volume":"62","author":"GW Jeon","year":"2019","unstructured":"Jeon GW (2019) Surfactant preparations for preterm infants with respiratory distress syndrome: past, present, and future. Korean J Pediatr 62(5):155\u2013161","journal-title":"Korean J Pediatr"},{"issue":"8","key":"6793_CR70","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41372-023-01690-9","volume":"43","author":"V Bhandari","year":"2023","unstructured":"Bhandari V et al (2023) RDS-next workshop: consensus statements for the use of surfactant in preterm neonates with RDS. J Perinatol 43(8):982\u2013990","journal-title":"J Perinatol"},{"issue":"2","key":"6793_CR71","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000513783","volume":"118","author":"D De Luca","year":"2021","unstructured":"De Luca D et al (2021) Personalized Medicine for the Management of RDS in Preterm Neonates. Neonatology 118(2):127\u2013138","journal-title":"Neonatology"},{"issue":"3","key":"6793_CR72","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/MOP.0000000000000751","volume":"31","author":"LM Nogee","year":"2019","unstructured":"Nogee LM (2019) Genetic causes of surfactant protein abnormalities. Curr Opin Pediatr 31(3):330\u2013339","journal-title":"Curr Opin Pediatr"},{"key":"6793_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.618867","volume":"9","author":"G Ferrante","year":"2021","unstructured":"Ferrante G et al (2021) Biomarkers of Oxidative Stress for Neonatal Lung Disease. Front Pediatr 9:618867","journal-title":"Front Pediatr"},{"key":"6793_CR74","first-page":"675","volume":"15","author":"N Yalcin","year":"2022","unstructured":"Yalcin N et al (2022) The impact of pharmacogenetics on pharmacokinetics and pharmacodynamics in neonates and infants: a systematic review. Pharmacogenomics Pers Med 15:675\u2013696","journal-title":"Pharmacogenomics Pers Med"},{"key":"6793_CR75","doi-asserted-by":"publisher","DOI":"10.2196\/47612","volume":"25","author":"W Jang","year":"2023","unstructured":"Jang W et al (2023) Artificial Intelligence-driven respiratory distress syndrome prediction for very low birth weight infants: Korean multicenter prospective cohort study. J Med Internet Res 25:e47612","journal-title":"J Med Internet Res"},{"issue":"9","key":"6793_CR76","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1002\/ppul.26563","volume":"58","author":"A Perri","year":"2023","unstructured":"Perri A et al (2023) The future of neonatal lung ultrasound: validation of an artificial intelligence model for interpreting lung scans. A multicentre prospective diagnostic study. Pediatr Pulmonol 58(9):2610\u20132618","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"6793_CR77","doi-asserted-by":"publisher","first-page":"F497","DOI":"10.1136\/archdischild-2017-312722","volume":"102","author":"DG Sweet","year":"2017","unstructured":"Sweet DG et al (2017) A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 102(6):F497\u2013F503","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"Pt A","key":"6793_CR78","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejpb.2015.02.014","volume":"95","author":"A Hidalgo","year":"2015","unstructured":"Hidalgo A, Cruz A, Perez-Gil J (2015) Barrier or carrier? Pulmonary surfactant and drug delivery. Eur J Pharm Biopharm 95(Pt A):117\u2013127","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"6793_CR79","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.xphs.2021.12.002","volume":"111","author":"JS Katz","year":"2022","unstructured":"Katz JS et al (2022) Emerging Challenges and Innovations in Surfactant-mediated Stabilization of Biologic Formulations. J Pharm Sci 111(4):919\u2013932","journal-title":"J Pharm Sci"},{"issue":"8","key":"6793_CR80","doi-asserted-by":"publisher","first-page":"951","DOI":"10.4155\/tde.13.72","volume":"4","author":"N El-Gendy","year":"2013","unstructured":"El-Gendy N et al (2013) Delivery and performance of surfactant replacement therapies to treat pulmonary disorders. Ther Deliv 4(8):951\u2013980","journal-title":"Ther Deliv"},{"issue":"3","key":"6793_CR81","first-page":"91","volume":"50","author":"N Nouraeyan","year":"2014","unstructured":"Nouraeyan N et al (2014) Surfactant administration in neonates: A review of delivery methods. Can J Respir Ther 50(3):91\u201395","journal-title":"Can J Respir Ther"},{"key":"6793_CR82","unstructured":"Yadav, S., B. Lee, and R. Kamity, Neonatal Respiratory Distress Syndrome, in StatPearls. 2024: Treasure Island (FL) ineligible companies. Disclosure: Brian Lee declares no relevant financial relationships with ineligible companies. Disclosure: Ranjith Kamity declares no relevant financial relationships with ineligible companies"},{"key":"6793_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102097","volume":"62","author":"VV Ramaswamy","year":"2023","unstructured":"Ramaswamy VV et al (2023) Clinical decision thresholds for surfactant administration in preterm infants: a systematic review and network meta-analysis. EClinicalMedicine 62:102097","journal-title":"EClinicalMedicine"},{"issue":"3","key":"6793_CR84","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1001\/jamapediatrics.2018.4296","volume":"173","author":"S Foligno","year":"2019","unstructured":"Foligno S, De Luca D (2019) Carelessness about surfactant dose-a cultural problem, a legal issue, or an open research question? JAMA Pediatr 173(3):211\u2013212","journal-title":"JAMA Pediatr"},{"issue":"1","key":"6793_CR85","first-page":"251","volume":"5","author":"JW Logan","year":"2009","unstructured":"Logan JW, Moya FR (2009) Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials. Ther Clin Risk Manag 5(1):251\u2013260","journal-title":"Ther Clin Risk Manag"},{"key":"6793_CR86","doi-asserted-by":"crossref","unstructured":"Moya, F. and A. Maturana, Animal-derived surfactants versus past and current synthetic surfactants: current status. Clin Perinatol, 2007. 34(1): 145\u201377, viii","DOI":"10.1016\/j.clp.2006.12.005"},{"issue":"6","key":"6793_CR87","doi-asserted-by":"publisher","first-page":"L883","DOI":"10.1152\/ajplung.00186.2024","volume":"327","author":"FJ Walther","year":"2024","unstructured":"Walther FJ, Waring AJ (2024) Moving on from clinical animal-derived surfactants to peptide-based synthetic pulmonary surfactant. Am J Physiol Lung Cell Mol Physiol 327(6):L883\u2013L889","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"6793_CR88","doi-asserted-by":"crossref","unstructured":"Ramanathan R, et al (2020) Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial. J Pediatr 225 90\u201396 e1","DOI":"10.1016\/j.jpeds.2020.06.024"},{"issue":"3","key":"6793_CR89","volume":"16","author":"M Mylavarapu","year":"2024","unstructured":"Mylavarapu M et al (2024) Effect of surfactant therapy on clinical outcomes of COVID-19 patients with ARDS: a systematic review and meta-analysis. Cureus 16(3):e56238","journal-title":"Cureus"},{"key":"6793_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.622598","volume":"11","author":"A Watson","year":"2020","unstructured":"Watson A, Madsen J, Clark HW (2020) SP-A and SP-D: dual functioning immune molecules with antiviral and immunomodulatory properties. Front Immunol 11:622598","journal-title":"Front Immunol"},{"key":"6793_CR91","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.2147\/COPD.S114034","volume":"11","author":"DP Tashkin","year":"2016","unstructured":"Tashkin DP (2016) A review of nebulized drug delivery in COPD. Int J Chron Obstruct Pulmon Dis 11:2585\u20132596","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"6793_CR92","doi-asserted-by":"publisher","first-page":"L1","DOI":"10.1113\/jphysiol.1986.sp016172","volume":"275","author":"RJ Mason","year":"1998","unstructured":"Mason RJ, Greene K, Voelker DR (1998) Surfactant protein A and surfactant protein D in health and disease. Am J Physiol 275(1):L1-13","journal-title":"Am J Physiol"},{"issue":"2-3","key":"6793_CR93","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0925-4439(98)00065-9","volume":"1408","author":"J Johansson","year":"1998","unstructured":"Johansson J (1998) Structure and properties of surfactant protein C. Biochim Biophys Acta 1408(2\u20133):161\u2013172","journal-title":"Biochim Biophys Acta"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06793-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-06793-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06793-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T09:04:05Z","timestamp":1776935045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-06793-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":93,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["6793"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-06793-x","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}